283 related articles for article (PubMed ID: 34671398)
1. The Multifaceted Therapeutic Mechanisms of Curcumin in Osteosarcoma: State-of-the-Art.
Zahedipour F; Bolourinezhad M; Teng Y; Sahebkar A
J Oncol; 2021; 2021():3006853. PubMed ID: 34671398
[TBL] [Abstract][Full Text] [Related]
2. Targeting Signaling Pathway by Curcumin in Osteosarcoma.
Farnood PR; Pazhooh RD; Asemi Z; Yousefi B
Curr Mol Pharmacol; 2023; 16(1):71-82. PubMed ID: 35400349
[TBL] [Abstract][Full Text] [Related]
3. Curcumin inhibits proliferation and invasion of osteosarcoma cells through inactivation of Notch-1 signaling.
Li Y; Zhang J; Ma D; Zhang L; Si M; Yin H; Li J
FEBS J; 2012 Jun; 279(12):2247-59. PubMed ID: 22521131
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of natural compounds, curcumin and PKF118-310, as Wnt/β-catenin antagonists against human osteosarcoma cells.
Leow PC; Tian Q; Ong ZY; Yang Z; Ee PL
Invest New Drugs; 2010 Dec; 28(6):766-82. PubMed ID: 19730790
[TBL] [Abstract][Full Text] [Related]
5. The role of miR-21/RECK in the inhibition of osteosarcoma by curcumin.
Zhou L; Lu Y; Liu JS; Long SZ; Liu HL; Zhang J; Zhang T
Mol Cell Probes; 2020 Jun; 51():101534. PubMed ID: 32081769
[TBL] [Abstract][Full Text] [Related]
6. Functionalized curcumin analogs as potent modulators of the Wnt/β-catenin signaling pathway.
Leow PC; Bahety P; Boon CP; Lee CY; Tan KL; Yang T; Ee PL
Eur J Med Chem; 2014 Jan; 71():67-80. PubMed ID: 24275249
[TBL] [Abstract][Full Text] [Related]
7. Curcumin and its Analogs and Carriers: Potential Therapeutic Strategies for Human Osteosarcoma.
Lu KH; Lu PW; Lu EW; Lin CW; Yang SF
Int J Biol Sci; 2023; 19(4):1241-1265. PubMed ID: 36923933
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of curcumin action: signal transduction.
Shehzad A; Lee YS
Biofactors; 2013; 39(1):27-36. PubMed ID: 23303697
[TBL] [Abstract][Full Text] [Related]
9. Curcumin Analogue L48H37 Suppresses Human Osteosarcoma U2OS and MG-63 Cells' Migration and Invasion in Culture by Inhibition of uPA via the JAK/STAT Signaling Pathway.
Lu KH; Wu HH; Lin RC; Lin YC; Lu PW; Yang SF; Yang JS
Molecules; 2020 Dec; 26(1):. PubMed ID: 33374783
[TBL] [Abstract][Full Text] [Related]
10. Potential therapeutic effects of curcumin mediated by JAK/STAT signaling pathway: A review.
Ashrafizadeh M; Rafiei H; Mohammadinejad R; Afshar EG; Farkhondeh T; Samarghandian S
Phytother Res; 2020 Aug; 34(8):1745-1760. PubMed ID: 32157749
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms underlying the action of carcinogens in gastric cancer with a glimpse into targeted therapy.
Patrad E; Khalighfard S; Amiriani T; Khori V; Alizadeh AM
Cell Oncol (Dordr); 2022 Dec; 45(6):1073-1117. PubMed ID: 36149600
[TBL] [Abstract][Full Text] [Related]
12. Short communication: selective cytotoxicity of curcumin on osteosarcoma cells compared to healthy osteoblasts.
Chang R; Sun L; Webster TJ
Int J Nanomedicine; 2014; 9():461-5. PubMed ID: 24453488
[TBL] [Abstract][Full Text] [Related]
13. Curcumin in Osteosarcoma Therapy: Combining With Immunotherapy, Chemotherapeutics, Bone Tissue Engineering Materials and Potential Synergism With Photodynamic Therapy.
Xu C; Wang M; Guo W; Sun W; Liu Y
Front Oncol; 2021; 11():672490. PubMed ID: 34094974
[TBL] [Abstract][Full Text] [Related]
14. Curcumin Regulates Cancer Progression: Focus on ncRNAs and Molecular Signaling Pathways.
Wang H; Zhang K; Liu J; Yang J; Tian Y; Yang C; Li Y; Shao M; Su W; Song N
Front Oncol; 2021; 11():660712. PubMed ID: 33912467
[TBL] [Abstract][Full Text] [Related]
15. Curcumin and quercetin synergistically inhibit cancer cell proliferation in multiple cancer cells and modulate Wnt/β-catenin signaling and apoptotic pathways in A375 cells.
Srivastava NS; Srivastava RAK
Phytomedicine; 2019 Jan; 52():117-128. PubMed ID: 30599890
[TBL] [Abstract][Full Text] [Related]
16. Cellular and molecular mechanisms of curcumin in prevention and treatment of disease.
Patel SS; Acharya A; Ray RS; Agrawal R; Raghuwanshi R; Jain P
Crit Rev Food Sci Nutr; 2020; 60(6):887-939. PubMed ID: 30632782
[TBL] [Abstract][Full Text] [Related]
17. Apoptotic effects of curcumin on human osteosarcoma U2OS cells.
Jin S; Xu HG; Shen JN; Chen XW; Wang H; Zhou JG
Orthop Surg; 2009 May; 1(2):144-52. PubMed ID: 22009832
[TBL] [Abstract][Full Text] [Related]
18. The novel curcumin analog FLLL32 decreases STAT3 DNA binding activity and expression, and induces apoptosis in osteosarcoma cell lines.
Fossey SL; Bear MD; Lin J; Li C; Schwartz EB; Li PK; Fuchs JR; Fenger J; Kisseberth WC; London CA
BMC Cancer; 2011 Mar; 11():112. PubMed ID: 21443800
[TBL] [Abstract][Full Text] [Related]
19. Natural compounds targeting major cell signaling pathways: a novel paradigm for osteosarcoma therapy.
Angulo P; Kaushik G; Subramaniam D; Dandawate P; Neville K; Chastain K; Anant S
J Hematol Oncol; 2017 Jan; 10(1):10. PubMed ID: 28061797
[TBL] [Abstract][Full Text] [Related]
20. Modulation of apoptosis-related cell signalling pathways by curcumin as a strategy to inhibit tumor progression.
Chen J; Wang FL; Chen WD
Mol Biol Rep; 2014 Jul; 41(7):4583-94. PubMed ID: 24604727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
